Crosstalk between Long Non-Coding RNA and Spliceosomal microRNA as a Novel Biomarker for Cancer

被引:4
作者
Arafat, Maram [1 ]
Sperling, Ruth [1 ]
机构
[1] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel
关键词
lncRNA; miRNA; spliceosomal miRNA; cancer; supraspliceosome; MECHANISMS; EXPRESSION; TARGET;
D O I
10.3390/ncrna9040042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Non-coding RNAs (ncRNAs) play diverse roles in regulating cellular processes and have been implicated in pathological conditions, including cancer, where interactions between ncRNAs play a role. Relevant here are (i) microRNAs (miRNAs), mainly known as negative regulators of gene expression in the cytoplasm. However, identification of miRNAs in the nucleus suggested novel nuclear functions, and (ii) long non-coding RNA (lncRNA) regulates gene expression at multiple levels. The recent findings of miRNA in supraspliceosomes of human breast and cervical cancer cells revealed new candidates of lncRNA targets. Here, we highlight potential cases of crosstalk between lncRNA and supraspliceosomal miRNA expressed from the same genomic region, having complementary sequences. Through RNA:RNA base pairing, changes in the level of one partner (either miRNA or lncRNA), as occur in cancer, could affect the level of the other, which might be involved in breast and cervical cancer. An example is spliceosomal mir-7704 as a negative regulator of the oncogenic lncRNA HAGLR. Because the expression of spliceosomal miRNA is cell-type-specific, the list of cis-interacting lncRNA:spliceosomal miRNA presented here is likely just the tip of the iceberg, and such interactions are likely relevant to additional cancers. We thus highlight the potential of lncRNA:spliceosomal miRNA interactions as novel targets for cancer diagnosis and therapies.
引用
收藏
页数:23
相关论文
共 62 条
  • [1] The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy
    Aartsma-Rus, Annemieke
    Corey, David R.
    [J]. NUCLEIC ACID THERAPEUTICS, 2020, 30 (02) : 67 - 70
  • [2] Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome
    Agranat-Tamir, Lily
    Shomron, Noam
    Sperling, Joseph
    Sperling, Ruth
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (07) : 4640 - 4651
  • [3] A Quality Control Mechanism of Splice Site Selection Abrogated under Stress and in Cancer
    Arafat, Maram
    Sperling, Ruth
    [J]. CANCERS, 2022, 14 (07)
  • [4] Metazoan MicroRNAs
    Bartel, David P.
    [J]. CELL, 2018, 173 (01) : 20 - 51
  • [5] Long Noncoding RNA and Cancer: A New Paradigm
    Bhan, Arunoday
    Soleimani, Milad
    Mandal, Subhrangsu S.
    [J]. CANCER RESEARCH, 2017, 77 (15) : 3965 - 3981
  • [6] Long Noncoding RNAs: Emerging Stars in Gene Regulation, Epigenetics and Human Disease
    Bhan, Arunoday
    Mandal, Subhrangsu S.
    [J]. CHEMMEDCHEM, 2014, 9 (09) : 1932 - 1956
  • [7] Roles and mechanisms of alternative splicing in cancer - implications for care
    Bonnal, Sophie C.
    Lopez-Oreja, Irene
    Valcarcel, Juan
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (08) : 457 - 474
  • [8] Noncoding RNA:RNA Regulatory Networks in Cancer
    Chan, Jia Jia
    Tay, Yvonne
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [9] Nusinersen for the treatment of spinal muscular atrophy
    Chiriboga, Claudia A.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (10) : 955 - 962
  • [10] An Architectural Role for a Nuclear Noncoding RNA: NEAT1 RNA Is Essential for the Structure of Paraspeckles
    Clemson, Christine M.
    Hutchinson, John N.
    Sara, Sergio A.
    Ensminger, Alexander W.
    Fox, Archa H.
    Chess, Andrew
    Lawrence, Jeanne B.
    [J]. MOLECULAR CELL, 2009, 33 (06) : 717 - 726